PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported April 1, 2015

B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Recall #
D-0424-2015
Affected scope
UNKNOWN
Initiated
December 19, 2014
Compiled from official public sources by the editorial team.
Verify with FDA Drug →
View my saved recalls

Bethel Nutritional Consulting, Inc recalled B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consu… - a moderate-severity action.

B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consu… was recalled by Bethel Nutritional Consulting, Inc in April 1, 2015. Reason: Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight lo…. Check the official notice for the remedy. Verify recall #D-0424-2015 with the FDA Drug before acting.

The recall

Bethel Nutritional Consulting, Inc issued this moderate-severity FDA Drug recall-Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight lo….

Moderate
severity level
Class II
classification
April 1, 2015
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0424-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0424-2015) was formally reported on April 1, 2015, with the manufacturer initiating the action on December 19, 2014. It is classified under Moderate severity (Class II), with a current status of Terminated. Bethel Nutritional Consulting, Inc is listed as the recalling firm, operating out of New York, NY. Federal records list the affected scope as UNKNOWN.

The documented reason for this recall is: Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Dietary Supplements recalls over time

Where this recall sits in its category - 2,002 dietary supplements recalls on record

-1000100200300400 20072010201320162019202220252026 9
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Moderate

Affected scope

UNKNOWN

Related Recalls

6

0 from same agency

Product description

B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.

Reason for recall

Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-0424-2015
Date reported April 1, 2015
Date initiated December 19, 2014
Recalling firm Bethel Nutritional Consulting, Inc
Firm location New York, NY
Affected scope UNKNOWN
Distribution Nationwide

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0424-2015) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
B-Lipo, 30 Capsules, Manufactured by KM DALI, Kunming, China for Bethel Nutritional Consulting, Inc.599 West 190th Street, Suite #1 NYC, NY 10040.. Recalled by Bethel Nutritional Consulting, Inc. Units affected: UNKNOWN.
Why was this product recalled?
Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss
Which agency issued this recall?
This recall was issued by the FDA Drug on April 1, 2015. Severity: Moderate. Recall number: D-0424-2015.
Where was the recalled product distributed?
Distribution: Nationwide.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0424-2015) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →

Browse all Dietary Supplements recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported April 1, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.